This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Feb;62(2):190-1.

doi: 10.1136/gutjnl-2012-302410. Epub 2012 Jun 8.

Metronomic topotecan for colorectal cancer: a promising new option

Dingzhi Wang¹, Ofer Margalit, Raymond N DuBois

Affiliations

PMID: 22684481
DOI: 10.1136/gutjnl-2012-302410

Comment

Metronomic topotecan for colorectal cancer: a promising new option

Dingzhi Wang et al. Gut. 2013 Feb.

. 2013 Feb;62(2):190-1.

doi: 10.1136/gutjnl-2012-302410. Epub 2012 Jun 8.

Authors

Dingzhi Wang¹, Ofer Margalit, Raymond N DuBois

Affiliation

¹ Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas 77030, USA.

PMID: 22684481
DOI: 10.1136/gutjnl-2012-302410

No abstract available

PubMed Disclaimer

Comment on

Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models.
Hackl C, Man S, Francia G, Milsom C, Xu P, Kerbel RS. Hackl C, et al. Gut. 2013 Feb;62(2):259-71. doi: 10.1136/gutjnl-2011-301585. Epub 2012 Apr 28. Gut. 2013. PMID: 22543158 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information